C&EN eBook
Pure and simple: Affinity chromatography solutions for complex biotherapeutic manufacturing
Brought to you by Thermo Fisher Scientific

Biotherapeutics are a rapidly expanding class of drugs, yet manufacturing challenges may limit their clinical impact. This eBook explores how affinity chromatography can offer a viable solution to help accelerate biomanufacturing and ensure biotherapeutic production meets demand.

Key Objectives:
  • Biotherapeutic producers face many challenges that can create bottlenecks during the manufacturing process. In this eBook, learn how affinity chromatography can provide a viable solution to overcoming these challenges.
  • Biotherapeutic modalities are varied, which can make a one-size-fits-all approach to purification challenging. Learn more on affinity resins that have been designed to facilitate manufacturing of antibodies, vaccines, mRNA, and viral vectors.
  • Due to the diversity and speed of modern biopharmaceutical development, commercially available affinity resins may not always be viable options. This eBook describes how custom affinity resins can be fine-tuned to target virtually any molecule, expanding the application of affinity purification to additional biotherapeutic classes.

Brought to you by:
Please complete the form to download the eBook.
*I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com . By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Thermo Fisher Scientific Privacy Policy
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy .

Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy